Senator Hinojosa Announces $12 Million in Funding for Medical Residency

Translate to Spanish or other 102 languages!

Mega Doctor News                                                                                          

- Advertisement -

AUSTIN, TX – This past Friday, the Texas Higher Education Coordinating Board awarded a total of $12 million in funding to several Senate District 20 hospitals and The University of Texas Rio Grande Valley Medical School to expand their Graduate Medical Education (GME) programs. This funding is critical to ensure that Texas has the number of practicing physicians we need.

Research indicates that of students who complete their medical school and residency in Texas, close to 90% choose to remain, practicing close to the area in which they completed their residency. This is especially important for South Texas, an area known to have a shortage of doctors and access to care difficulties for our families.

 Senator Hinojosa issued the following statement:

- Advertisement -

“It is great news that several Senate District 20 hospitals and the UTRGV Medical School were awarded $12 million in funding to expand residency programs and residency slots.

This funding was made possible by the Legislature’s increased commitment to GME, and I was proud to joint-author Senate Bill 18 that promotes residency expansion programs and places emphasis on Texas’ most critical shortage areas. The goal of this legislation is to ensure that a residency slot is available for every Texas medical school graduate so that our students learn, train and ultimately practice here in Texas. 

 I will continue to advocate for continued GME support and growth to keep our doctors practicing right here in South Texas so that we can reduce our physician shortage, provide more care for our families, and ensure that our medical school is successful.”

Senate Bill 18 combines and streamlines existing residency programs and establishes a long-term funding source by creating a permanent endowment to support GME. This bill also encourages non-hospital entities, such as rural community clinics, to provide new residency programs by allowing them to partner with schools and hospitals to navigate the accreditation process.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -